Showing results (61-70 of 77) with videos related to

Sort By:
Pageof 8
BMJ Open|February 4, 2022
BOND study: a randomised double-blind, placebo-controlled trial over 12 months to assess the effects of benfotiamine on morphometric, neurophysiological and clinical measures in patients with type 2 diabetes with symptomatic polyneuropathyGidon J Bönhof, Gundega Sipola, Alexander Strom, et al.
Diabetes/Metabolism Research and Reviews|July 4, 2024
Association of transketolase polymorphisms with diabetic polyneuropathy in the general population: The KORA F4 studyDan Ziegler, Barbara Thorand, Alexander Strom, et al.
Diabetes/Metabolism Research and Reviews|March 27, 2018
Myeloperoxidase, superoxide dismutase-3, cardiometabolic risk factors, and distal sensorimotor polyneuropathy: The KORA F4/FF4 studyChristian Herder, Julia M Kannenberg, Cornelia Huth, et al.
Journal of the American Heart Association|September 6, 2025
Association of Inflammatory and Cardiovascular Proteomics Biomarkers With Indices of Heart Rate Variability in the General Population: KORA S4/FF4 StudyKolade Oluwagbemigun, Dan Ziegler, Alexander Strom, et al.
Diabetes|August 18, 2018
A Systemic Inflammatory Signature Reflecting Cross Talk Between Innate and Adaptive Immunity Is Associated With Incident Polyneuropathy: KORA F4/FF4 StudyChristian Herder, Julia M Kannenberg, Maren Carstensen-Kirberg, et al.
Diabetes Research and Clinical Practice|July 1, 2026
Health-related quality of life and management routine in painful and painless diabetic polyneuropathy (PREDIP study)Dan Ziegler, Charlotte Fietz, Winfried Keuthage, et al.
Diabetologia|December 6, 2022
Serum neurofilament light chain: a novel biomarker for early diabetic sensorimotor polyneuropathyHaifa Maalmi, Alexander Strom, Agnese Petrera, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|February 28, 2024
Association of dietary patterns with diabetes-related comorbidities varies among diabetes endotypesKatharina S Weber, Sabrina Schlesinger, Alexander Lang, et al.
BMJ Open Diabetes Research & Care|January 22, 2026
Effects of benfotiamine treatment over 12 months on morphometric, neurophysiological and clinical measures in type 2 diabetes patients with symptomatic polyneuropathy: a randomized, placebo-controlled, double-blind clinical trial (BOND study)Dan Ziegler, Gundega Sipola, Alexander Strom, et al.
The Journal of Clinical Endocrinology and Metabolism|December 16, 2019
Expansion and Impaired Mitochondrial Efficiency of Deep Subcutaneous Adipose Tissue in Recent-Onset Type 2 DiabetesKálmán Bódis, Tomas Jelenik, Jesper Lundbom, et al.
Pageof 8